Bromodomain and hedgehog pathway targets in small cell lung cancer
Open Access
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 371 (2) , 225-239
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (HHSN261200800001E)
This publication has 42 references indexed in Scilit:
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer CellsCancer Research, 2012
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Radiotherapy in small-cell lung cancer: Where should it go?Lung Cancer, 2010
- Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumorsProceedings of the National Academy of Sciences, 2010
- Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?Lung Cancer, 2010
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancerBritish Journal of Cancer, 2010
- Therapeutic Targeting of NOTCH1 Signaling in T-Cell Acute Lymphoblastic LeukemiaClinical Lymphoma Myeloma and Leukemia, 2009